Cognishine Therapy and Education

A Global All In One Platform For Allied Health Therapeutic Services

Health Tech & Life Sciences
Active
Pre-Seed Lehavim Founded 2021
Total raised
$4.4M
Last: Pre-Seed 2024-05
Stage
Pre-Seed
Founded
2021
Headcount
25
HQ
Lehavim
Sector
Health Tech & Life Sciences

About

Cognishine is an AI-driven, multilingual, and multicultural digital platform designed for health and elderly care organizations, along with their Allied Health therapists, to treat patients with various disorders. Our all-in-one platform integrates therapy tools, workflows, and content for intervention, assessment, and reporting across multiple professional groups, including speech-language pathologists (SLPs), occupational therapists (OTs), mental health professionals, physiotherapists, and dietitians.

Allied health organizations remain reliant on outdated methods and processes, struggling to transition to digital solutions due to the fragmented options currently available. Cognishine addresses this challenge by providing a comprehensive platform specifically designed for large organizations, enhanced through collaboration with top global healthcare institutions and professionals. We help providers achieve a seamless digital transformation, improving productivity, patient outcomes, and accessibility.

With a $17B market opportunity, our platform aligns with leading therapy standards, offering an extensive selection of activities while allowing therapists to customize their own materials. Suitable for one-on-one, one-to-many, and group therapy, both in-person and via teletherapy, Cognishine also supports independent asynchronous practice on any device.

Additionally, we provide comprehensive management tools for hospitals, rehabilitation clinics, elderly care facilities, and therapy practices to optimize therapeutic services. Trusted by major health organizations such as Sheba Medical Center, Ichilov, and Israel’s largest HMOs, we already serve approximately 50% of health and elderly care organizations in Israel. In 2024, we began our international expansion, focusing on the US, UK, and DACH markets.

Funding history · 1 round · $4.4M total

2024-05
Pre-Seed $1.3M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient EngagementDigital TherapeuticsClinical WorkflowMedical DevicesAssistive Devices
Technologies
Platforms & InterfacesWeb
Target customers
Enterprise & Professional ServicesEducationHealthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

Verified

Tags

therapeuticssaastherapeutic-devicescommunicationsteachershealthcare-providersmental-healthvideopersonalizationdigital-healthcareweb-platformedtechdigital-therapeuticssmbrehabilitation